 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
| «123 |
- | vidofludimus (IMU-838) / Immunic
Trial initiation date: CALDOSE-1: Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (clinicaltrials.gov) - Mar 3, 2018
P2, N=150, Not yet recruiting, Sponsor: Immunic AG
Initiation date: Jan 2018 --> Mar 2018
- | vidofludimus (IMU-838) / Immunic
New P2 trial: CALDOSE-1: Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (clinicaltrials.gov) - Nov 14, 2017
P2, N=150, Not yet recruiting, Sponsor: Immunic AG
- |||| vidofludimus (IMU-838) / Immunic
Trial completion, Combination therapy: COMPONENT: SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (clinicaltrials.gov) - Feb 28, 2012
P2, N=266, Completed, Sponsor: 4SC AG
Initiation date: Jan 2018 --> Mar 2018 Active, not recruiting --> Completed